XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel · Delayed Price · Currency is ILS · Price in ILA 4.900
-0.100 (-2.00%)
Aug 14, 2025, 5:24 PM IDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of 44.07 million as of August 14, 2025. Its market cap has decreased by -11.13% in one year.
Market Cap
44.07M
Enterprise Value
40.41M
Revenue
1.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.90
Market Cap Chart
Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 44.07M, a decrease of -94.53%. That is a compound annual growth rate of -13.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 44.07M | -45.95% |
| Dec 31, 2024 | 81.53M | 327.50% |
| Dec 31, 2023 | 19.07M | -14.63% |
| Dec 29, 2022 | 22.34M | -52.02% |
| Dec 30, 2021 | 46.56M | -7.60% |
| Dec 31, 2020 | 50.39M | 108.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 64.35B |
| Danel (Adir Yeoshua) | 2.50B |
| Kamada | 1.43B |
| Bait Bakfar | 1.06B |
| SofWave Medical | 977.04M |
| BrainsWay | 772.64M |
| Novolog (Pharm-Up 1966) | 709.61M |
| Ilex Medical | 673.41M |